S. Gampenrieder, R. Angela, G. Rinnerthaler, H. Hackl, M. Steiner, Walter Pulverer, A. Weinhaeusel, E. Klinglmayr, T. Karl, S. Ilic, C. Hufnagl, C. Hauser-kronberger, A. Egle, R. Greil
{"title":"摘要P3-10-07:在TANIA III期试验中,3基因DNA甲基化标记无法预测转移性乳腺癌患者对贝伐单抗的反应","authors":"S. Gampenrieder, R. Angela, G. Rinnerthaler, H. Hackl, M. Steiner, Walter Pulverer, A. Weinhaeusel, E. Klinglmayr, T. Karl, S. Ilic, C. Hufnagl, C. Hauser-kronberger, A. Egle, R. Greil","doi":"10.1158/1538-7445.SABCS18-P3-10-07","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20307,"journal":{"name":"Poster Session Abstracts","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract P3-10-07: A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial\",\"authors\":\"S. Gampenrieder, R. Angela, G. Rinnerthaler, H. Hackl, M. Steiner, Walter Pulverer, A. Weinhaeusel, E. Klinglmayr, T. Karl, S. Ilic, C. Hufnagl, C. Hauser-kronberger, A. Egle, R. Greil\",\"doi\":\"10.1158/1538-7445.SABCS18-P3-10-07\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20307,\"journal\":{\"name\":\"Poster Session Abstracts\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster Session Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-P3-10-07\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Session Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-P3-10-07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract P3-10-07: A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial